title: Heart and lung transplantation in patients with end stage lung disease.
abstract: Combined heart and lung transplantation was used to treat seven patients with end stage lung disease. All were severely disabled, and their disease carried a poor prognosis. Six patients were well four to 33 months after transplantation. One patient died after 44 days from a primary cytomegalovirus pneumonia transmitted from the donor. All the survivors had normal exercise tolerance and greatly improved lung function. It is concluded that heart and lung transplantation is a suitable treatment for selected patients with end stage chronic lung disease.
mesh_terms: D000328:Adult; D002908:Chronic Disease; D005260:Female; D005541:Forced Expiratory Volume; D006321:Heart / Q000503:physiopathology; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008171:Lung Diseases / Q000503:physiopathology / Q000601:surgery*; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis